News

Filter

Current filters:

USAOphthalmics

101 to 110 of 96886 results

AstraZeneca and Amgen's  brodalumab achieves primary endpoint in Phase III trial for plaque psoriasis

AstraZeneca and Amgen's brodalumab achieves primary endpoint in Phase III trial for plaque psoriasis

12-11-2014

Anglo-Swedish drug major AstraZeneca and USA-based Amgen, the world’s largest independent biotech firm,…

AmgenAstraZenecaBiotechnologybrodalumabDermatologicalsResearchStelara

Durect to ‘refine the path’ of Posidur program

Durect to ‘refine the path’ of Posidur program

12-11-2014

US drugmaker Durect Corporation says that it has received meeting minutes from its face-to-face meeting…

AnalgesiaDurectPharmaceuticalPosidurRegulationUSA

Servier gains ex-US/Japan rights to Intarcia diabetes product ITCA 650

Servier gains ex-US/Japan rights to Intarcia diabetes product ITCA 650

12-11-2014

USA-based biotech firm Intarcia Therapeutics has started a strategic partnership with French independent…

BiotechnologyDiabetesexenatide pumpFranceIntarcia TherapeuticsITCA 650LicensingServier

New data show strong cure rates with AbbVie’s hep C therapy in HIV and transplant patient studies

New data show strong cure rates with AbbVie’s hep C therapy in HIV and transplant patient studies

11-11-2014

US pharma company AbbVie got a boost for its upcoming hepatitis C treatment regimen, with the company…

AbbVieAnti-viralsPharmaceuticalResearchUSA

AVEO inks deal with Ophthotech for tivozanib in ocular diseases

AVEO inks deal with Ophthotech for tivozanib in ocular diseases

11-11-2014

US biotech firm AVEO Oncology has entered into a research and exclusive option agreement with Ophthotech…

AVEO OncologyBiotechnologyLicensingOphthalmicsOphthotechtivozanibUSA

Positive Ph III results with Highland Therapeutics’ HLD-200 in ADHD

11-11-2014

Ironshore Pharmaceuticals & Development, part of Canada-based specialty pharma company Highland Therapeutics,…

Highland TherapeuticsHLD-200Ironshore PharmaceuticalsMethylphenidate HclNeurologicalPharmaceuticalResearch

Biologics will complement statins in cholesterol treatment space, says GlobalData

Biologics will complement statins in cholesterol treatment space, says GlobalData

11-11-2014

Biologics will play an influential role in shaping the future of cardiovascular drug treatment, in particular…

alirocumabAmgenCardio-vascularevolocumabMarkets & MarketingPharmaceuticalRegeneronSanofiUSA

101 to 110 of 96886 results

Back to top